glutathione in the treatment of chronic fatty liver diseases schollar Immunological mechanisms and therapeutic targets Therapeutic effects of reduced glutathione
Description
Reprod Domest Anim 2017;52:561-569
Jastreboff, MD, PhD Director, Weight Management & Obesity Prevention Yale School of Medicine, New Haven, Connecticut Professor Ania Jastreboff has been a principal investigator for pivotal GLP3 clinical trials, including the landmark phase 2 obesity study published in the New England Journal of Medicine
E., Mendell, J
A common autoimmune-mediated disease of the CNS that is characterized by multiple acute inflammatory foci involving immune-mediated demyelination that can undergo spontaneous remyelination
